nDatalyze Corp. Share Price

Equities

NDAT

CA63948H1055

IT Services & Consulting

Market Closed - Canadian Securities Exchange 20:52:57 26/04/2024 BST 5-day change 1st Jan Change
0.15 CAD +3.45% Intraday chart for nDatalyze Corp. 0.00% +11.11%

Financials

Sales 2022 0.42 0.58 34.02 Sales 2023 0.17 0.23 13.71 Capitalization 7.36M 10.05M 589M
Net income 2022 -1M -1.37M -80.05M Net income 2023 -1M -1.37M -80.05M EV / Sales 2022 16,324,966 x
Net cash position 2022 1.6M 2.18M 128M Net cash position 2023 743K 1.02M 59.46M EV / Sales 2023 38,621,739 x
P/E ratio 2022
-7.02 x
P/E ratio 2023
-5.95 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 72.12%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.45%
Current month-3.23%
1 month-6.25%
3 months+11.11%
6 months-6.25%
Current year+11.11%
More quotes
1 week
0.15
Extreme 0.145
0.15
1 month
0.14
Extreme 0.14
0.17
Current year
0.12
Extreme 0.115
0.17
1 year
0.04
Extreme 0.04
0.18
3 years
0.04
Extreme 0.04
0.36
5 years
0.00
Extreme 0
0.36
10 years
0.00
Extreme 0
0.36
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 23/01/18
Director of Finance/CFO 59 31/03/19
Members of the board TitleAgeSince
Chief Executive Officer 70 23/01/18
Director/Board Member 71 20/02/18
Director/Board Member 44 18/03/18
More insiders
Date Price Change Volume
26/04/24 0.15 +3.45% 31,500
24/04/24 0.145 -3.33% 6,000
23/04/24 0.15 0.00% 28,000
19/04/24 0.15 0.00% 2,000
18/04/24 0.15 0.00% 1,000

Delayed Quote Canadian Securities Exchange, April 26, 2024 at 08:52 pm

More quotes
nDatalyze Corp. is a Canada-based company that generates technology-based, health-related solutions. The Company, through its subsidiary, Mindbalanced Inc., offers mental healthcare through a personalized approach by utilizing advanced AI and biometric data analysis. It delivers insights into mental health conditions, facilitating personalized treatment plans designed to enhance patient outcomes. It generates technologically based solutions focusing on applying machine learning to predict potential benefits associated with the use of entheogenic compounds within the mental health sector and is developing a data-driven consumer mHealth application. Its machine-learning processed; online consumer mental health application known as YMI is based on its Reference Database consisting of more than 1200 biometric records complete with associated electroencephalogram data. YMI is designed to provide an advanced digital, objective, quantifiable tool for predictive mental health screening.
More about the company